These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 18475000

  • 21. Generics battle brand names over mortality of drug patents.
    Betz R.
    J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008
    [No Abstract] [Full Text] [Related]

  • 22. Who's really raising drug prices?
    Zagorin A.
    Time; 1999 Mar 08; 153(9):46-8. PubMed ID: 10346086
    [No Abstract] [Full Text] [Related]

  • 23. Biosimilar competition in the United States: statutory incentives, payers, and pharmacy benefit managers.
    Falit BP, Singh SC, Brennan TA.
    Health Aff (Millwood); 2015 Feb 08; 34(2):294-301. PubMed ID: 25646110
    [Abstract] [Full Text] [Related]

  • 24. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug 12; 430(7001):716. PubMed ID: 15306779
    [No Abstract] [Full Text] [Related]

  • 25. Biotech industry struggles with generics approval.
    Knight J.
    Nature; 2004 Jun 10; 429(6992):588. PubMed ID: 15190316
    [No Abstract] [Full Text] [Related]

  • 26. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR.
    Suffolk Univ Law Rev; 2003 Jun 10; 36(3):787-819. PubMed ID: 16493844
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The new drug war.
    Sherrid P.
    US News World Rep; 2002 Dec 02; 133(21):41. PubMed ID: 12503485
    [No Abstract] [Full Text] [Related]

  • 30. SuperGenerics: a better alternative for biogenerics.
    Charles SA.
    Drug Discov Today; 2005 Apr 15; 10(8):533-5. PubMed ID: 15837591
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1.
    Kuhrt K, Chace-Ortiz M.
    IDrugs; 2009 Dec 15; 12(12):760-4. PubMed ID: 19943217
    [Abstract] [Full Text] [Related]

  • 35. Regulators can challenge deals that delay generic competition, says US Supreme Court.
    McCarthy M.
    BMJ; 2013 Jun 19; 346():f3964. PubMed ID: 23783361
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hatch-Waxman Turns 30: Do We Need a Re-Designed Approach for the Modern Era?
    Kesselheim AS, Darrow JJ.
    Yale J Health Policy Law Ethics; 2015 Jun 19; 15(2):293-347. PubMed ID: 26333236
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prozac. A bitter pill.
    McLean B.
    Fortune; 2001 Aug 13; 144(3):118-22, 126, 130-2. PubMed ID: 11499050
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.